Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 7, Number 1—February 2001

Research

Lack of Evidence of Endogenous Avian Leukosis Virus and Endogenous Avian Retrovirus Transmission to Measles Mumps Rubella Vaccine Recipients

Althaf I. Hussain*, Vedapuri Shanmugam*, William M. Switzer*, Shirley X. Tsang*, Aly Fadly†, Donald Thea‡, Rita Helfand*, William J. Bellini*, Thomas M. Folks*, and Walid Heneine*Comments to Author 
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Avian Disease and Oncology Laboratory, U.S. Department of Agriculture, East Lansing, Michigan, USA; ‡Harvard Institute for International Development, Cambridge, Massachusetts, USA

Main Article

Figure 3

Reverse transcriptase-polymerase chain reaction analysis of sera from measles mumps rubella (MMR) vaccine recipients for the presence of avian leukosis virus (ALV) (A) and endogenous avian retrovirus (EAV) (B) RNA. Lanes 1-10, samples from MMR vaccine recipients. NC, negative control, uninfected human serum; PC, positive control, culture supernatant from Rous-associated virus 0 (RAV-0) infected 15B1 chick embryo fibroblasts.

Figure 3. Reverse transcriptase-polymerase chain reaction analysis of sera from measles mumps rubella (MMR) vaccine recipients for the presence of avian leukosis virus (ALV) (A) and endogenous avian retrovirus (EAV) (B) RNA. Lanes 1-10, samples from MMR vaccine recipients. NC, negative control, uninfected human serum; PC, positive control, culture supernatant from Rous-associated virus 0 (RAV-0) infected 15B1 chick embryo fibroblasts.

Main Article

TOP